Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Jong‐Seon Park, Mahn‐Won Park et al.|The Lancet|2021Cited by 202
Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary interventionEun Ho Choo, Ki‐Bae Seung, Kiyuk Chang et al.|Heart|2014Cited by 79
Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial InfarctionIk Jun Choi, Kiyuk Chang, Sungmin Lim et al.|JACC: Cardiovascular Interventions|2021Cited by 69
The impact of no-reflow phenomena after primary percutaneous coronary interventionEun Ho Choo, Ki‐Bae Seung, Pum Joon Kim et al.|Coronary Artery Disease|2014Cited by 42
Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non–Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)Ik Jun Choi, Pum-Joon Kim, Eun Ho Choo et al.|The American Journal of Cardiology|2016Cited by 28